GIVN CH0010645932

Report

Delayed Swiss Exchange - 09/24 11:31:26 am
4372	CHF		-3.04%

09/20	GIVAUDAN AG : UBS keeps its Buy rating	MD
09/16	GIVAUDAN : AlphaValue/Baader Europe Lowers Price Target on Givaudan	MT
09/10	GIVAUDAN : AlphaValue/Baader Europe Lowers Price Target on Givaudan	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

09/20/2021	09/21/2021	09/22/2021	09/23/2021	09/24/2021	Date
4464(c)	4513(c)	4457(c)	4509(c)	4372(c)	Last
16 000	12 395	9 673	10 210	15 487	Volume
-0.56%	+1.10%	-1.24%	+1.17%	-3.04%	Change

More quotes

Estimated financial data (e)

Sales 2021	6 652 M 7 193 M 7 193 M
Net income 2021	868 M 938 M 938 M
Net Debt 2021	3 854 M 4 167 M 4 167 M
P/E ratio 2021	46,7x
Yield 2021	1,53%

Sales 2022	6 984 M 7 552 M 7 552 M
Net income 2022	970 M 1 049 M 1 049 M
Net Debt 2022	3 557 M 3 846 M 3 846 M
P/E ratio 2022	42,0x
Yield 2022	1,61%

Capitalization	40 344 M 43 598 M 43 624 M
EV / Sales 2021	6,64x
EV / Sales 2022	6,29x
Nbr of Employees	16 130
Free-Float	85,9%

More Financials

Company

Givaudan SA is a Switzerland-based company engaged in the fragrance and flavor industry. The Company has two business divisions: Fragrances and Flavors. The Fragrances segment comprises the manufacture and sale of fragrances through four business units: Fine Fragrances, comprising fragrances; Consumer Products, comprising personal care, hair and skin care, household care, and oral care; Fragrance Ingredients; and...

Sector

Specialty Chemicals

Calendar

09/30

Presentation

More about the company

Ratings of Givaudan SA

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

All news about GIVAUDAN SA

09/20	GIVAUDAN AG : UBS keeps its Buy rating	MD
09/16	GIVAUDAN : AlphaValue/Baader Europe Lowers Price Target on Givaudan	MT
09/10	GIVAUDAN : AlphaValue/Baader Europe Lowers Price Target on Givaudan	MT
09/07	GIVAUDAN : Establishes Hub At Swiss Center To Accelerate Protein Development	MT
08/30	Ginkgo Bioworks, Inc. and Givaudan Enter Multi-Program Collaboration to Produce A Serie..	CI
08/27	GIVAUDAN AG : JP Morgan reiterates its Neutral rating	MD
08/26	GIVAUDAN : Moody's Raises Givaudan's Outlook Citing Potential for Continued Growth	MT
08/26	EMEA MORNING BRIEFING : Shares to Fall, Commodities Weaken as Focus Turns to Fed	DJ
08/23	GIVAUDAN AG : UBS reiterates its Buy rating	MD
08/20	GIVAUDAN AG : Bernstein remains a Sell rating	MD
08/18	GIVAUDAN AG : Gets a Neutral rating from JP Morgan	MD
08/10	GIVAUDAN AG : Barclays reiterates its Sell rating	MD
08/06	GIVAUDAN : CK One maker Firmenich scents strong rebound for fine fragrances	RE
07/29	PRIVI SPECIALITY CHEMICALS : Forms JV With Swiss Company to Set Up New Manufacturing Unit	MT
07/29	GIVAUDAN : Forms JV With Privi Speciality Chemicals	MT

More news

News in other languages on GIVAUDAN SA

09/24	Aktien Schweiz Schluss: Investoren gehen vor dem Wochenende in Deckung
09/24	Bourse Zurich: dans le rouge pour la dernière séance de la semaine
09/24	Aktien Schweiz schließen schwächer - Evergrande-Krise belastet
09/24	ZURICH STOCK EXCHANGE : 4-Wochenvorschau Schweiz
09/23	Aktien Schweiz Vorbörse: Fortsetzung der Erholung erwartet - SNB im Fokus

More news

Analyst Recommendations on GIVAUDAN SA

09/20	GIVAUDAN AG : UBS keeps its Buy rating	MD
09/16	GIVAUDAN : AlphaValue/Baader Europe Lowers Price Target on Givaudan	MT
09/10	GIVAUDAN : AlphaValue/Baader Europe Lowers Price Target on Givaudan	MT

More recommendations

Stock Trading Strategies

	GIVAUDAN SA - 2020
Good timing to go long again

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

Perfume recovery helps Givaudan H1 net profit beat poll